ArticleAnnals of medicine and surgery (2012)2025

Therapeutic efficacy and safety profile of SGLT-2 inhibitor dapagliflozin in heart failure with reduced and preserved ejection fraction: a systematic review and meta-analysis.

Mohammed Muthanna Al-Ezzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.